Fig 1.
Selection of sample for cohort and case-control study from HDSS population.
Fig 2.
Illustration of cohort and case-control study designs.
Table 1.
Primer and probe "long DNA repeat (LDR)" target sequences for W. bancrofti.
Table 2.
Proportion of individuals who progressed to clinical VL in follow up period, by Leishmania serostatus at baseline (n = 1,560*).
Table 3.
Analysis of risk of progression to clinical VL in follow up period and exposure to prior Wuchereria bancrofti (LF) infection (n = 1,560*).
Table 4.
Analysis of odds of prior Wuchereria bancrofti (LF) infection and progression to clinical VL in follow up period (n = 107).